随着油价下跌 富时指数走低

    中国石化新闻网讯 据路透社7月20日报道，因对疫情的担忧加剧，周一能源类股票随着油价下跌，富时100指数下跌，。

    以大宗商品为主的蓝筹股指数下跌0.9%，英国石油公司(BP Plc)和荷兰皇家壳牌公司(Royal Dutch Shell Plc)跌幅最大。富时250指数下跌0.5%，金融、非必需消费品和房地产类股领跌。

    欧洲股市本周开局也不乐观，欧盟领导人仍在就疫情恢复基金的条款进行谈判，此前欧盟领导人就该计划谈判了三天。

    FXTM市场策略师Hussein Sayed表示："在股市从3月低点大幅上涨后，市场需要另一剂利好消息来维持涨势，但鉴于未来的诸多不确定性，市场似乎趋于下行。"

    在3月份疫情引发崩盘后，富时100指数已反弹了约27%，但由于担心全球经济复苏慢于预期，自6月份以来，涨幅有所放缓。

    最近的一项调查显示，近一半的英国大公司认为，企业要到2021年下半年才能从疫情中恢复过来。

    当天晚些时候，所有人都将目光聚焦于阿斯利康公司(AstraZeneca Plc)和牛津大学(Oxford University)开发的一种疫苗的早期人体试验数据。数据公布前，阿斯利康的股价攀升5%，创下历史新高。

    王佳晶 摘译自 路透社

    原文如下：

    Oil stocks drag FTSE lower; M&S hit by job cuts report

    The FTSE 100 fell on Monday, with energy stocks tracking a decline in oil prices on concerns about the global spike in COVID-19 cases, while Marks and Spencer (MKS.L) slid after a report that the retailer was planning to cut hundreds of jobs.

    The commodity-heavy blue-chip index .FTSE was down 0.9%, with BP Plc (BP.L) and Royal Dutch Shell Plc (RDSa.L) among the biggest drags. The mid-cap FTSE 250 .FTMC shed 0.5%, led by financials, consumer discretionary and real-estate stocks.

    Stock markets in Europe also kicked off the week on a glum note with EU leaders still negotiating the terms of a coronavirus recovery fund after three days of haggling over the plan.

    “Following the (steep rise) from March lows, markets need another dose of positive news to keep the rally going, but given the many uncertainties ahead, the risks seem tilted to the downside,” said Hussein Sayed, market strategist at FXTM.

    The FTSE 100 has bounced about 27% following a coronavirus-driven crash in March, but the pace of gains has slowed since June amid fears of a slower-than-expected global economic recovery.

    A recent survey showed that nearly half of Britain’s biggest companies think they will take until the second half of 2021 before businesses recover from the pandemic.

    Later in the day, all eyes are expected to be on early-stage human trial data on a vaccine being developed by AstraZeneca Plc (AZN.L) and Oxford University. AstraZeneca’s shares climbed 5% to a record high ahead of the data.